Fobumix Easyhaler 320/9 (budesonide/formoterol) is...
The JAK inhibitor tofacitinib (Xeljanz) has been endorsed...
Aloflute (salmeterol/fluticasone) metered dose inhaler...
NICE has approved the use of reslizumab (Cinqaero)...
The hexavalent DTaP/IPV/HiB/HBV vaccine Infanrix hexa...
New and deleted products
Instructions for changing or stopping antidepressants.
Summary of NICE guidance on Helicobacter treatment.
Hormone doses and costs of HRT preparations.
Strengths and formulations of topical steroids.
Dose regimens for common bacterial infections.
Featured MIMS resources
New products coming soon to MIMS
Check back soon to find MIMS listings for the following new drugs:
Fertavid (follitropin beta)
Panzyga (human normal immunoglobulin)
Suliqua (insulin glargine/lixisenatide)
Vemlidy (tenofovir alafenamide fumarate)
Partner CPD from MIMS Learning
Initiated, funded and reviewed by Reckitt Benckiser. Date of Preparation: February 2017; UK/E45-NHS/0916/0013j
Lessons from the Ealing GP Federation Funding for this educational programme has been provided by Bayer, Boehringer Ingelheim and Daiichi Sankyo. None of the companies have had any influence or input into its content.
This learning module has been initiated, funded and reviewed by Edwards Lifesciences.
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.